Search - tctmd.com

Displaying 101 - 120 of 243

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Central Aortic Insufficiency Due to Transcatheter Heart Valve Defect After Transapical Transcatheter Aortic Valve Replacement

Presenter: A. Pieter Kappetein, Dee Dee Wang, Chad Morreale, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Combined TAVR With Sapien 3 Valve and Paravalvular Leak Closure for Severe Paravalvular Leak

Presenter: A. Pieter Kappetein, Dee Dee Wang, Cenap Undemir, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Aortic Valve Replacement for Severe Aortic Insufficiency in a Patient With Prior Type A Aortic Dissection Repair and Residual Type B Dissection Extending to the Infrarenal Aorta

Presenter: A. Pieter Kappetein, Dee Dee Wang, Hasan Ahmad, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Counterpoint: A "Selective" Minimalist Strategy Makes More Sense, and "Extreme" Minimalism Is Dangerous!

Presenter: Eberhard Grube, Howard C. Herrmann, Susheel K. Kodali

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve With Left Ventricular Outflow Tract Aneurysm

Presenter: A. Pieter Kappetein, Dee Dee Wang, Arijit Chanda, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Point: A Minimalist Strategy Should Be Used in ALL TAVR Patients!

Presenter: Eberhard Grube, Howard C. Herrmann, Vinod H. Thourani

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

ViV in a Patient With a "Ghost" Valve and Extremely Low Left Main Trunk Takeoff

Presenter: A. Pieter Kappetein, Dee Dee Wang, Costantino Costantini, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Contemporaneous Transcatheter Heart Valve Replacement in Native Aortic and Mitral Valve Stenosis

Presenter: Isaac George, Christopher U. Meduri, Marcus R. Burns

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Presenter: Susheel K. Kodali, Michael J. Reardon, Patrick M. McCarthy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

Presenter: Susheel K. Kodali, Michael J. Reardon, Mathew Williams

June 21, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Perspectives From the STS/ACC TVT Registry: Factors That Impact Clinical Outcomes

Presenter: Michael J. Mack, John D. Carroll

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

Presenter: Michael J. Mack, Bernard Prendergast

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to VARC-3: A Focused Update New Endpoints and Definitions for Aortic Valve Clinical Research

Presenter: Michael J. Mack, Nicolo Piazza

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Presenter: Michael J. Mack

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Innovative FDA Approaches to Future Clinical Research: Proposal for a Cardiac Device Coordinated Research Network (CDCRN)

Presenter: Michael J. Mack, John C Laschinger

June 21, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Staffing the Structural Heart and Valve Center: The Roles of Cardiovascular Team Professionals

Presenter: Elizabeth M. Perpetua, Susan J. Schnell

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Simultaneous Transcatheter Aortic and Mitral Valve Replacement

Presenter: Patrick M. McCarthy, David Meerkin, Sachin Goel, MD

June 21, 2018

Advertisement

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Central Aortic Insufficiency Due to Transcatheter Heart Valve Defect After Transapical Transcatheter Aortic Valve Replacement

Combined TAVR With Sapien 3 Valve and Paravalvular Leak Closure for Severe Paravalvular Leak

Transcatheter Aortic Valve Replacement for Severe Aortic Insufficiency in a Patient With Prior Type A Aortic Dissection Repair and Residual Type B Dissection Extending to the Infrarenal Aorta

Counterpoint: A "Selective" Minimalist Strategy Makes More Sense, and "Extreme" Minimalism Is Dangerous!

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve With Left Ventricular Outflow Tract Aneurysm

Point: A Minimalist Strategy Should Be Used in ALL TAVR Patients!

ViV in a Patient With a "Ghost" Valve and Extremely Low Left Main Trunk Takeoff

Contemporaneous Transcatheter Heart Valve Replacement in Native Aortic and Mitral Valve Stenosis

Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Perspectives From the STS/ACC TVT Registry: Factors That Impact Clinical Outcomes

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

An Introduction to VARC-3: A Focused Update New Endpoints and Definitions for Aortic Valve Clinical Research

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Innovative FDA Approaches to Future Clinical Research: Proposal for a Cardiac Device Coordinated Research Network (CDCRN)

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Staffing the Structural Heart and Valve Center: The Roles of Cardiovascular Team Professionals

Simultaneous Transcatheter Aortic and Mitral Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content